Your browser doesn't support javascript.
loading
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis.
Yoshifuji, Ayumi; Toda, Masataro; Ryuzaki, Munekazu; Oyama, Emi; Kikuchi, Kan; Kawai, Toru; Sakai, Ken; Koinuma, Masayoshi; Katayama, Kazuhiko; Yokoyama, Takashi; Uehara, Yuki; Ohmagari, Norio; Kanno, Yoshihiko; Kon, Hirofumi; Shinoda, Toshio; Takano, Yaoko; Tanaka, Junko; Hora, Kazuhiko; Nakazawa, Yasushi; Hasegawa, Naoki; Hanafusa, Norio; Hinoshita, Fumihiko; Morikane, Keita; Wakino, Shu; Nakamoto, Hidetomo; Takemoto, Yoshiaki.
Afiliação
  • Yoshifuji A; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Toda M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.
  • Ryuzaki M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.
  • Oyama E; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Kikuchi K; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.
  • Kawai T; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Sakai K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Koinuma M; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Katayama K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Yokoyama T; Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo 164-8530, Japan.
  • Uehara Y; Laboratory of Viral Infection Control, Omura Satoshi Memorial Institute, Graduate School of Infection Control Sciences, Kitasato University, Tokyo 108-8641, Japan.
  • Ohmagari N; Department of Infectious Diseases, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Kanno Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Kon H; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Shinoda T; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Takano Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Tanaka J; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Hora K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Nakazawa Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Hasegawa N; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Hanafusa N; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Hinoshita F; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Morikane K; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Wakino S; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Nakamoto H; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
  • Takemoto Y; Infection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Vaccines (Basel) ; 11(3)2023 Mar 14.
Article em En | MEDLINE | ID: mdl-36992238

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article